'Less is more': The role of purging in hematopoietic stem cell transplantation

Oncologist

Volumn 2, Issue 4, 1997, Pages 268-274

  Lowdell, Mark W ^a   Theocharous, Panteli ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; BONE MARROW PURGING; CHRONIC MYELOID LEUKEMIA; COST EFFECTIVENESS ANALYSIS; HEMATOPOIETIC STEM CELL; LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REVIEW; SOLID TUMOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0030858776     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-4-268     Document Type: Review

References (15)

1. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-86.
2. Cole-Sinclair MF, Foroni L, Hoffbrand AV. Genetic Changes in ALL. Bailliere's Clin Haematol 1994;7:183-233.
3. Adriaansen HJ, Jacobs BC, Kappers-Klunne MC et al. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers. Leukemia 1993;7:472-481.
4. Tkachuk DC, Westbrook CA, Andreef M et al. Detection of BCR-ABL fusion in chronic myelogenous leukemia by two-color fluorescence in situ hybridization. Science 1990;250:559-562.
5. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991;325:1525-1533.
6. Pantel K, Schlimok G, Angstwurm M et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3:165-173.
7. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumour cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-2610.
8. Brugger W, Brass KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-640.
9. Moss TJ, Sanders DO, Lasky LC et al. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990;76:1879-1883.
10. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 1992;79:1074-1080.
11. Sharp JG, Kessinger A, Vaughan WP et al. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 1992;10:92-94.
12. Sharp JG, Bishop M, Chan WC et al. Detection of minimal residual disease (MRD) in hematopoietic tissues. In: Sackstein R, Janssen WE, Elfenbein GJ, eds. Bone Marrow Transplantation: Foundations of the 21st Century. New York: New York Academy of Sciences, 1995:242-261.
13. Datta YH, Adams PT, Drobyski WR et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-482.
14. Krismann M, Todt B, Schröder J et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995;13:2769-2775.
15. Williams CD, Goldstone AH, Pearce RM et al. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. J Clin Oncol 1996;14:2454-2464.